Amicus Therapeutics, Inc. (FOLD)
USD 6.67
(-0.15%)
USD 6.67
(-0.15%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -151.58 Million USD | 35.92% |
| 2022 | -236.56 Million USD | 5.55% |
| 2021 | -250.46 Million USD | 9.53% |
| 2020 | -276.85 Million USD | 22.32% |
| 2019 | -356.38 Million USD | -2.12% |
| 2018 | -348.99 Million USD | -22.88% |
| 2017 | -284 Million USD | -41.97% |
| 2016 | -200.04 Million USD | -51.41% |
| 2015 | -132.11 Million USD | -91.68% |
| 2014 | -68.92 Million USD | -15.58% |
| 2013 | -59.63 Million USD | -22.24% |
| 2012 | -48.78 Million USD | -9.85% |
| 2011 | -44.41 Million USD | 19.16% |
| 2010 | -54.93 Million USD | -736.55% |
| 2009 | -6.56 Million USD | 83.31% |
| 2008 | -39.35 Million USD | 4.4% |
| 2007 | -41.16 Million USD | 11.17% |
| 2006 | -46.34 Million USD | -132.05% |
| 2005 | -19.97 Million USD | -126.77% |
| 2004 | -8.8 Million USD | -30.13% |
| 2003 | -6.76 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -15.69 Million USD | 67.58% |
| 2024 Q1 | -48.41 Million USD | -43.07% |
| 2023 Q2 | -43.23 Million USD | 18.33% |
| 2023 Q1 | -52.93 Million USD | 5.25% |
| 2023 Q4 | -33.84 Million USD | -56.85% |
| 2023 FY | -151.58 Million USD | 35.92% |
| 2023 Q3 | -21.57 Million USD | 50.09% |
| 2022 Q3 | -33.28 Million USD | 46.45% |
| 2022 Q2 | -62.15 Million USD | 27.1% |
| 2022 Q1 | -85.26 Million USD | -2.38% |
| 2022 FY | -236.56 Million USD | 5.55% |
| 2022 Q4 | -55.86 Million USD | -67.83% |
| 2021 Q3 | -50.29 Million USD | 1.82% |
| 2021 Q1 | -65.66 Million USD | 8.03% |
| 2021 Q4 | -83.27 Million USD | -65.58% |
| 2021 Q2 | -51.22 Million USD | 21.99% |
| 2021 FY | -250.46 Million USD | 9.53% |
| 2020 Q4 | -71.4 Million USD | -11.54% |
| 2020 Q1 | -88.94 Million USD | 0.87% |
| 2020 FY | -276.85 Million USD | 22.32% |
| 2020 Q2 | -52.49 Million USD | 40.99% |
| 2020 Q3 | -64.01 Million USD | -21.94% |
| 2019 Q1 | -120.29 Million USD | -54.07% |
| 2019 Q3 | -61.8 Million USD | 26.9% |
| 2019 Q4 | -89.72 Million USD | -45.17% |
| 2019 FY | -356.38 Million USD | -2.12% |
| 2019 Q2 | -84.55 Million USD | 29.72% |
| 2018 Q4 | -78.08 Million USD | 50.94% |
| 2018 Q2 | -61.83 Million USD | -23.87% |
| 2018 FY | -348.99 Million USD | -22.88% |
| 2018 Q1 | -49.91 Million USD | 27.88% |
| 2018 Q3 | -159.16 Million USD | -157.41% |
| 2017 Q1 | -54.99 Million USD | 6.23% |
| 2017 Q4 | -69.2 Million USD | 38.02% |
| 2017 Q3 | -111.66 Million USD | -131.98% |
| 2017 Q2 | -48.13 Million USD | 12.47% |
| 2017 FY | -284 Million USD | -41.97% |
| 2016 Q3 | -46.65 Million USD | 8.61% |
| 2016 Q4 | -58.64 Million USD | -25.71% |
| 2016 Q2 | -51.05 Million USD | -16.84% |
| 2016 FY | -200.04 Million USD | -51.41% |
| 2016 Q1 | -43.69 Million USD | -1.85% |
| 2015 FY | -132.11 Million USD | -91.68% |
| 2015 Q2 | -27.13 Million USD | -11.71% |
| 2015 Q4 | -42.89 Million USD | -13.48% |
| 2015 Q3 | -37.8 Million USD | -39.31% |
| 2015 Q1 | -24.28 Million USD | -14.46% |
| 2014 Q1 | -15.94 Million USD | -30.29% |
| 2014 Q4 | -21.21 Million USD | -23.73% |
| 2014 Q3 | -17.14 Million USD | -17.35% |
| 2014 Q2 | -14.61 Million USD | 8.34% |
| 2014 FY | -68.92 Million USD | -15.58% |
| 2013 Q3 | -14.58 Million USD | 4.95% |
| 2013 Q2 | -15.34 Million USD | 12.08% |
| 2013 FY | -59.63 Million USD | -22.24% |
| 2013 Q4 | -12.23 Million USD | 16.12% |
| 2013 Q1 | -17.45 Million USD | -74.32% |
| 2012 Q2 | -9.34 Million USD | 28.88% |
| 2012 FY | -48.78 Million USD | -9.85% |
| 2012 Q3 | -16.29 Million USD | -74.36% |
| 2012 Q4 | -10.01 Million USD | 38.52% |
| 2012 Q1 | -13.13 Million USD | -51.66% |
| 2011 Q4 | -8.66 Million USD | 11.24% |
| 2011 FY | -44.41 Million USD | 19.16% |
| 2011 Q1 | -13.35 Million USD | 11.52% |
| 2011 Q2 | -12.64 Million USD | 5.31% |
| 2011 Q3 | -9.75 Million USD | 22.8% |
| 2010 Q4 | -15.08 Million USD | 1.75% |
| 2010 FY | -54.93 Million USD | -736.55% |
| 2010 Q3 | -15.35 Million USD | -35.72% |
| 2010 Q2 | -11.31 Million USD | 14.12% |
| 2010 Q1 | -13.17 Million USD | -139.98% |
| 2009 Q4 | 32.95 Million USD | 345.41% |
| 2009 Q2 | -13.62 Million USD | -9.23% |
| 2009 Q1 | -12.47 Million USD | 11.86% |
| 2009 FY | -6.56 Million USD | 83.31% |
| 2009 Q3 | -13.42 Million USD | 1.42% |
| 2008 FY | -39.35 Million USD | 4.4% |
| 2008 Q4 | -14.15 Million USD | -72.98% |
| 2008 Q3 | -8.18 Million USD | 11.99% |
| 2008 Q2 | -9.29 Million USD | -20.22% |
| 2008 Q1 | -7.73 Million USD | 34.33% |
| 2007 Q2 | -9.39 Million USD | 3.08% |
| 2007 Q3 | -10.3 Million USD | -9.65% |
| 2007 Q4 | -11.77 Million USD | -14.27% |
| 2007 FY | -41.16 Million USD | 11.17% |
| 2007 Q1 | -9.69 Million USD | 16.32% |
| 2006 Q1 | -11.58 Million USD | -132.05% |
| 2006 FY | -46.34 Million USD | -132.05% |
| 2006 Q2 | -11.58 Million USD | 0.0% |
| 2006 Q3 | -11.58 Million USD | 0.0% |
| 2006 Q4 | -11.58 Million USD | 0.0% |
| 2005 Q3 | -4.99 Million USD | 0.0% |
| 2005 Q4 | -4.99 Million USD | 0.0% |
| 2005 Q1 | -4.99 Million USD | 0.0% |
| 2005 FY | -19.97 Million USD | -126.77% |
| 2005 Q2 | -4.99 Million USD | 0.0% |
| 2004 FY | -8.8 Million USD | -30.13% |
| 2003 FY | -6.76 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Sangamo Therapeutics, Inc. | -257.83 Million USD | 41.208% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -34.191% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -16094.872% |
| Autolus Therapeutics plc | -208.38 Million USD | 27.257% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -1604.761% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -421.481% |
| Shattuck Labs, Inc. | -87.29 Million USD | -73.64% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -21.607% |
| CervoMed Inc. | -2.17 Million USD | -6879.414% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | 38.279% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -239.849% |
| Aptose Biosciences Inc. | -51.2 Million USD | -196.022% |
| Precision BioSciences, Inc. | -61.31 Million USD | -147.206% |
| Dyadic International, Inc. | -6.79 Million USD | -2130.665% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -69.903% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -1338.451% |
| Nektar Therapeutics | -276.05 Million USD | 45.089% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -26540.422% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -432.771% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -114.117% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -86.189% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | 32.704% |
| GRI Bio, Inc. | -13.03 Million USD | -1062.721% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -3566.251% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -22.162% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -1399.792% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -196.299% |
| IGM Biosciences, Inc. | -246.41 Million USD | 38.485% |
| INmune Bio, Inc. | -30 Million USD | -405.145% |
| Opthea Limited | -220.24 Million USD | 31.174% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -153.973% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -55.586% |
| Verastem, Inc. | -87.36 Million USD | -73.503% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -179.737% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | 6.045% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -29.939% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 390.647% |
| NextCure, Inc. | -62.72 Million USD | -141.672% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -696.6% |
| Organovo Holdings, Inc. | -14.67 Million USD | -933.222% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -2879.814% |
| Arvinas, Inc. | -367.3 Million USD | 58.73% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -189.62% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -462.714% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -346.229% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -0.33% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -409.955% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | 7.893% |
| Senti Biosciences, Inc. | -92.91 Million USD | -63.136% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -1355.061% |
| Apollomics, Inc. | -172.6 Million USD | 12.177% |
| PureTech Health plc | -65.69 Million USD | -130.732% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -283.961% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -106.667% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -3.145% |
| Synaptogenix, Inc. | -6.03 Million USD | -2410.291% |
| ChromaDex Corporation | -4.93 Million USD | -2969.745% |
| Beam Therapeutics Inc. | -132.52 Million USD | -14.38% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -1704.1% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -191.929% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -5.305% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 71.325% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -1844.709% |
| Gritstone bio, Inc. | -138.49 Million USD | -9.455% |
| Mesoblast Limited | -87.95 Million USD | -72.341% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -897.952% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -143.489% |
| Fate Therapeutics, Inc. | -160.92 Million USD | 5.806% |
| MediWound Ltd. | -6.71 Million USD | -2157.058% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | 15.341% |
| Fortress Biotech, Inc. | -60.63 Million USD | -149.986% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -96.63% |
| Achilles Therapeutics plc | -69.66 Million USD | -117.59% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -33.291% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -192.368% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -403.702% |
| Zai Lab Limited | -334.62 Million USD | 54.7% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -2562.171% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | 35.395% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 6141.61% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -11.547% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -1874.894% |
| FibroGen, Inc. | -284.23 Million USD | 46.669% |
| Celcuity Inc. | -63.77 Million USD | -137.67% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -477.859% |
| ContextLogic Inc. | -317 Million USD | 52.182% |
| GH Research PLC | -35.58 Million USD | -325.953% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -85.81% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -572.064% |
| ImmuCell Corporation | -5.77 Million USD | -2525.014% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 407.654% |
| Amarin Corporation plc | -59.11 Million USD | -156.435% |
| TG Therapeutics, Inc. | 12.67 Million USD | 1296.212% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -770.622% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -135.142% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -54.008% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -607.444% |
| Aptorum Group Limited | -2.82 Million USD | -5266.476% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 75.012% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | 33.087% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -525.837% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | 26.156% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -717.336% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -29.783% |
| Ardelyx, Inc. | -66.06 Million USD | -129.44% |
| Ainos, Inc. | -13.77 Million USD | -1000.784% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -141.838% |
| Prothena Corporation plc | -147.02 Million USD | -3.099% |
| HilleVax, Inc. | -123.56 Million USD | -22.675% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -33.119% |
| Celularity Inc. | -196.29 Million USD | 22.777% |
| Rallybio Corporation | -74.56 Million USD | -103.294% |
| Cue Biopharma, Inc. | -50.73 Million USD | -198.788% |
| Omeros Corporation | -117.81 Million USD | -28.665% |
| Humacyte, Inc. | -110.77 Million USD | -36.838% |
| Immunocore Holdings plc | -55.28 Million USD | -174.177% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -742.883% |
| Blueprint Medicines Corporation | -506.98 Million USD | 70.101% |
| IO Biotech, Inc. | -86.08 Million USD | -76.091% |
| MEI Pharma, Inc. | 17.77 Million USD | 952.649% |
| GT Biopharma, Inc. | -7.59 Million USD | -1895.314% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -123.988% |
| Summit Therapeutics Inc. | -614.92 Million USD | 75.349% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -331.372% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -7.198% |
| Scholar Rock Holding Corporation | -165.78 Million USD | 8.568% |
| Pulmatrix, Inc. | -14.12 Million USD | -973.465% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -330.698% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -49.835% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -83.431% |
| Acelyrin, Inc. | -381.64 Million USD | 60.281% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 68.498% |
| Cytokinetics, Incorporated | -526.24 Million USD | 71.195% |
| Vor Biopharma Inc. | -117.86 Million USD | -28.61% |
| Evogene Ltd. | -23.87 Million USD | -534.8% |
| Replimune Group, Inc. | -215.79 Million USD | 29.755% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -26.57% |
| PDS Biotechnology Corporation | -42.94 Million USD | -252.995% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -1832.141% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 76.433% |
| AEON Biopharma, Inc. | -52.55 Million USD | -188.424% |
| BioLineRx Ltd. | -60.61 Million USD | -150.081% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -269.123% |
| Atai Life Sciences N.V. | -40.22 Million USD | -276.85% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -100.718% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -416.259% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | 48.122% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -443.78% |
| MediciNova, Inc. | -8.57 Million USD | -1668.462% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -22.962% |
| MiMedx Group, Inc. | 67.43 Million USD | 324.772% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -1709.562% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | 36.639% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 75.809% |
| Mereo BioPharma Group plc | -29.46 Million USD | -414.437% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | 27.596% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -402.766% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | 35.752% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -3063.625% |
| Allakos Inc. | -185.7 Million USD | 18.372% |
| scPharmaceuticals Inc. | -54.81 Million USD | -176.563% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -55.734% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 242.815% |
| NLS Pharmaceutics AG | -12.17 Million USD | -1145.347% |
| Precigen, Inc. | -95.9 Million USD | -58.058% |
| XOMA Corporation | -40.83 Million USD | -271.247% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -48.801% |
| Incyte Corporation | 597.59 Million USD | 125.366% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -1423.802% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -27.905% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -72.885% |
| Seer, Inc. | -86.27 Million USD | -75.695% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -522.795% |
| CRISPR Therapeutics AG | -153.61 Million USD | 1.319% |
| Akero Therapeutics, Inc. | -151.75 Million USD | 0.115% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -331.63% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -1773.271% |
| Akari Therapeutics, Plc | -10 Million USD | -1414.628% |
| Novavax, Inc. | -545.06 Million USD | 72.19% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -2174.363% |
| UroGen Pharma Ltd. | -102.24 Million USD | -48.257% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -41.942% |
| Entera Bio Ltd. | -8.88 Million USD | -1605.299% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -627.37% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -44.781% |
| Chimerix, Inc. | -82.09 Million USD | -84.645% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -95.875% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | 24.807% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -156.998% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 136.541% |
| AnaptysBio, Inc. | -163.61 Million USD | 7.356% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -961.011% |
| Portage Biotech Inc. | -75.33 Million USD | -101.203% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -56.83% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -119.814% |
| OKYO Pharma Limited | -16.82 Thousand USD | -900820.391% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -1029.773% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -1713.838% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -1262.979% |
| AbCellera Biologics Inc. | -146.39 Million USD | -3.542% |
| Genprex, Inc. | -30.86 Million USD | -391.192% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | 35.749% |
| NLS Pharmaceutics AG | -12.17 Million USD | -1145.347% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -2762.228% |
| Daré Bioscience, Inc. | -30.16 Million USD | -402.576% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -2621.925% |
| Bicycle Therapeutics plc | -180.66 Million USD | 16.096% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | 65.262% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -91.988% |
| Erasca, Inc. | -125.04 Million USD | -21.226% |
| bluebird bio, Inc. | -211.91 Million USD | 28.469% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -517.626% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 190.42% |
| DBV Technologies S.A. | -72.72 Million USD | -108.432% |
| Fortress Biotech, Inc. | -60.63 Million USD | -149.986% |
| Avidity Biosciences, Inc. | -212.22 Million USD | 28.572% |
| CorMedix Inc. | -46.33 Million USD | -227.118% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -36.073% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -344.515% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -208.599% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -216.334% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -7.18% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | 31.007% |
| Cogent Biosciences, Inc. | -192.41 Million USD | 21.218% |
| Onconetix, Inc. | -37.4 Million USD | -305.2% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -1417.965% |
| Prime Medicine, Inc. | -198.13 Million USD | 23.494% |
| Adagene Inc. | -18.94 Million USD | -700.069% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | 37.196% |
| GlycoMimetics, Inc. | -36.89 Million USD | -310.803% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -27.35% |
| Verve Therapeutics, Inc. | -200.06 Million USD | 24.234% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 214.55% |
| SciSparc Ltd. | -5.12 Million USD | -2859.469% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -125953.187% |
| Minerva Neurosciences, Inc. | -30 Million USD | -405.19% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -107.96% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 764.667% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -225052.618% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | 42.174% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -979.205% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | 65.568% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -1435.183% |
| 2seventy bio, Inc. | -217.57 Million USD | 30.329% |
| ADMA Biologics, Inc. | -28.23 Million USD | -436.79% |
| Clene Inc. | -49.5 Million USD | -206.206% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -580.129% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -206.639% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | 53.795% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -365.797% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 767.183% |
| Absci Corporation | -110.56 Million USD | -37.098% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 103.834% |
| Surrozen, Inc. | -43.04 Million USD | -252.177% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -48.51% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -160.038% |
| Cingulate Inc. | -23.53 Million USD | -544.08% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -2093.056% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -1865.898% |
| Jaguar Health, Inc. | -41.3 Million USD | -267.031% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -68.035% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -147.339% |
| Kronos Bio, Inc. | -112.67 Million USD | -34.534% |
| Innoviva, Inc. | 179.72 Million USD | 184.344% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -119.062% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -2167.524% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -54.209% |
| Soligenix, Inc. | -6.14 Million USD | -2368.501% |
| AlloVir, Inc. | -190.41 Million USD | 20.394% |
| Century Therapeutics, Inc. | -136.67 Million USD | -10.91% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -50.535% |
| Kura Oncology, Inc. | -152.63 Million USD | 0.686% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 26906.727% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -110.832% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -599.575% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -305.956% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -37.107% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -259.257% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -849.676% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -859.697% |
| HCW Biologics Inc. | -24.99 Million USD | -506.475% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -14.409% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | 45.103% |
| Coherus BioSciences, Inc. | -237.89 Million USD | 36.28% |
| Lantern Pharma Inc. | -15.96 Million USD | -849.683% |
| Histogen Inc. | -10.62 Million USD | -1327.21% |
| Surrozen, Inc. | -43.04 Million USD | -252.177% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -275.896% |
| Kodiak Sciences Inc. | -260.49 Million USD | 41.808% |
| MoonLake Immunotherapeutics | -36 Million USD | -320.982% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -209.823% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -29.377% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -380.548% |
| Moderna, Inc. | -4.71 Billion USD | 96.784% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | 58.616% |
| Turnstone Biologics Corp. | -55.2 Million USD | -174.609% |
| Immix Biopharma, Inc. | -15.42 Million USD | -882.65% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -835.242% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -94.289% |
| Exelixis, Inc. | 207.76 Million USD | 172.959% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -11.992% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -163.565% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -28233.458% |
| Alkermes plc | 355.75 Million USD | 142.609% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -135.142% |
| Arcellx, Inc. | -70.69 Million USD | -114.435% |
| ESSA Pharma Inc. | -26.58 Million USD | -470.243% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -3689.647% |
| Avid Bioservices, Inc. | -140.75 Million USD | -7.695% |
| Insmed Incorporated | -749.56 Million USD | 79.777% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -265.783% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -13.278% |
| Moolec Science SA | -51.78 Million USD | -192.696% |
| RenovoRx, Inc. | -10.23 Million USD | -1381.47% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -189.443% |
| Geron Corporation | -184.12 Million USD | 17.674% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -261.138% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -126.262% |
| Royalty Pharma plc | 1.13 Billion USD | 113.357% |
| OmniAb, Inc. | -50.61 Million USD | -199.461% |
| Alector, Inc. | -130.39 Million USD | -16.253% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -11.495% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | 11.7% |
| Humacyte, Inc. | -110.77 Million USD | -36.838% |
| Structure Therapeutics Inc. | -89.62 Million USD | -69.141% |
| Revance Therapeutics, Inc. | -323.98 Million USD | 53.213% |
| 89bio, Inc. | -142.18 Million USD | -6.607% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -1360.769% |
| Aura Biosciences, Inc. | -76.4 Million USD | -98.388% |
| Immunic, Inc. | -93.61 Million USD | -61.928% |
| Veracyte, Inc. | -74.4 Million USD | -103.731% |
| Genelux Corporation | -28.29 Million USD | -435.689% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -421.534% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -2064.901% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -704.898% |
| Immunovant, Inc. | -259.33 Million USD | 41.549% |
| Vericel Corporation | -3.18 Million USD | -4663.796% |
| Fortrea Holdings Inc. | -3.4 Million USD | -4358.353% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -19.693% |
| XBiotech Inc. | -24.55 Million USD | -517.274% |
| Agenus Inc. | -245.76 Million USD | 38.321% |
| Acasti Pharma Inc. | -12.85 Million USD | -1079.367% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -1111.325% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -574.971% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -849.676% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -174.644% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -122.085% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -1115.589% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -580.74% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -414.001% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -456.517% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | 17.92% |
| United Therapeutics Corporation | 984.8 Million USD | 115.392% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -2767.339% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -3063.625% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -2879.814% |
| Silo Pharma, Inc. | -3.7 Million USD | -3996.109% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -1059.62% |
| Pharming Group N.V. | -10.54 Million USD | -1337.088% |
| XOMA Corporation | -40.83 Million USD | -271.247% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -522.795% |
| Bionomics Limited | -15.49 Billion USD | 99.022% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -419.889% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -105.426% |
| uniQure N.V. | -308.47 Million USD | 50.861% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -98.398% |
| Cassava Sciences, Inc. | -97.21 Million USD | -55.923% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -3925.385% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -647.05% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -22.81% |
| Pluri Inc. | -20.88 Million USD | -625.699% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -1748.202% |
| MeiraGTx Holdings plc | -84.02 Million USD | -80.399% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -561.044% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -765.89% |
| CalciMedica, Inc. | -34.35 Million USD | -341.203% |
| Sana Biotechnology, Inc. | -283.25 Million USD | 46.485% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -1208444.579% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -419.889% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -44.543% |
| Nutriband Inc. | -5.48 Million USD | -2663.452% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -275.022% |
| Compugen Ltd. | -18.75 Million USD | -708.276% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 103.486% |
| ProKidney Corp. | -35.46 Million USD | -327.382% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -2931.379% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -3423.966% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -48.986% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -87.952% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -229.18% |
| Benitec Biopharma Inc. | -21.75 Million USD | -596.906% |
| GeoVax Labs, Inc. | -25.96 Million USD | -483.762% |
| Biomea Fusion, Inc. | -117.25 Million USD | -29.277% |
| Cullinan Oncology, Inc. | -153.16 Million USD | 1.03% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -50.326% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 1176.285% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -580.97% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | 55.257% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | 21.444% |
| Imunon, Inc. | -19.51 Million USD | -676.757% |
| BioAtla, Inc. | -123.46 Million USD | -22.778% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | 53.682% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -310.252% |
| Zura Bio Limited | -60.36 Million USD | -151.133% |
| aTyr Pharma, Inc. | -50.38 Million USD | -200.828% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | 59.429% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | 36.238% |
| Galecto, Inc. | -38.34 Million USD | -295.275% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -225052.618% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 153.831% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | 14.417% |
| PolyPid Ltd. | -23.86 Million USD | -535.173% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -863.539% |
| Forte Biosciences, Inc. | -31.47 Million USD | -381.586% |
| Xencor, Inc. | -126.08 Million USD | -20.222% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -612.782% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -2174.363% |
| Instil Bio, Inc. | -156.08 Million USD | 2.885% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -1709.562% |
| OncoCyte Corporation | -27.78 Million USD | -445.639% |
| Elevation Oncology, Inc. | -45.7 Million USD | -231.665% |
| Purple Biotech Ltd. | -19.88 Million USD | -662.495% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -2059.624% |
| MacroGenics, Inc. | -9.05 Million USD | -1573.482% |
| Verona Pharma plc | -54.36 Million USD | -178.806% |
| Tharimmune, Inc. | -9.31 Million USD | -1526.596% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -80.489% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -51.71% |
| Aditxt, Inc. | -32.38 Million USD | -368.129% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -8406.397% |
| Savara Inc. | -54.69 Million USD | -177.129% |
| Curis, Inc. | -47.41 Million USD | -219.71% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -881.438% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -408.415% |
| BeiGene, Ltd. | -881.7 Million USD | 82.808% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -2931.379% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -277.478% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -1038.36% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -151.017% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -504.137% |
| Adicet Bio, Inc. | -142.65 Million USD | -6.257% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -1973.164% |
| Quantum-Si incorporated | -95.96 Million USD | -57.966% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -939.83% |
| Generation Bio Co. | -126.61 Million USD | -19.723% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -83.867% |
| Invivyd, Inc. | -198.64 Million USD | 23.69% |
| Relay Therapeutics, Inc. | -341.97 Million USD | 55.674% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -1645.038% |
| Moolec Science SA | -51.78 Million USD | -192.696% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -366.628% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -178.534% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -53.438% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | 5.734% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 75.355% |
| Evaxion Biotech A/S | -22.12 Million USD | -585.125% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -87.753% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -119.261% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -280.291% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -154.75% |
| Clearmind Medicine Inc. | -11.95 Million USD | -1167.952% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -130.493% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 312.273% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -5976645.011% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -76.476% |
| Keros Therapeutics, Inc. | -152.99 Million USD | 0.92% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | 29.341% |
| ImmunityBio, Inc. | -583.19 Million USD | 74.008% |
| Korro Bio, Inc. | -81.17 Million USD | -86.744% |
| Kineta, Inc. | -14.09 Million USD | -975.14% |
| BioVie Inc. | -32.12 Million USD | -371.922% |
| Codexis, Inc. | -76.24 Million USD | -98.825% |
| Celularity Inc. | -196.29 Million USD | 22.777% |
| Virax Biolabs Group Limited | -6.73 Million USD | -2151.179% |
| Cibus, Inc. | -267.62 Million USD | 43.36% |
| Annexon, Inc. | -134.23 Million USD | -12.923% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -147.573% |
| Eyenovia, Inc. | -27.26 Million USD | -456.045% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 802.07% |
| NeurAxis, Inc. | -14.62 Million USD | -936.353% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -404.658% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -256.719% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -613.564% |
| Notable Labs, Ltd. | -11.26 Million USD | -1245.739% |
| IN8bio, Inc. | -30 Million USD | -405.162% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -682.127% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -57.916% |
| Lumos Pharma, Inc. | -34.03 Million USD | -345.39% |
| Liquidia Corporation | -78.5 Million USD | -93.096% |
| Mustang Bio, Inc. | -51.6 Million USD | -193.756% |
| Quantum-Si incorporated | -95.96 Million USD | -57.966% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -108.08% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -51.71% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -178.826% |
| 180 Life Sciences Corp. | -19.93 Million USD | -660.387% |
| Vaxcyte, Inc. | -402.26 Million USD | 62.317% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | 16.892% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -1973.164% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -82.733% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 5138.039% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -5976645.011% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -288.797% |
| PepGen Inc. | -78.62 Million USD | -92.791% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -409.201% |
| Solid Biosciences Inc. | -96.01 Million USD | -57.875% |
| Palisade Bio, Inc. | -12.3 Million USD | -1132.39% |
| Nutriband Inc. | -5.48 Million USD | -2663.452% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -28233.458% |
| Immuneering Corporation | -53.47 Million USD | -183.485% |
| Belite Bio, Inc | -31.63 Million USD | -379.211% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -211.856% |
| GeoVax Labs, Inc. | -25.96 Million USD | -483.762% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -259.852% |
| Altimmune, Inc. | -88.44 Million USD | -71.384% |
| Peak Bio, Inc. | -1259.26 USD | -12037445.86% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -477.859% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -819.527% |
| Neurogene Inc. | -36.31 Million USD | -317.391% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | 7.24% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -1683.131% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -54.446% |
| Sesen Bio, Inc. | -19.88 Million USD | -662.342% |
| argenx SE | -295.05 Million USD | 48.625% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -82.733% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -248.029% |
| Immunome, Inc. | -106.8 Million USD | -41.925% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -876527.151% |
| Design Therapeutics, Inc. | -66.86 Million USD | -126.712% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -300.148% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -111.757% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | 65.862% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -35.869% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -12.187% |
| Athira Pharma, Inc. | -117.67 Million USD | -28.819% |
| XOMA Corporation | -40.83 Million USD | -271.247% |
| Merus N.V. | -154.93 Million USD | 2.165% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -382.982% |
| Rezolute, Inc. | -68.45 Million USD | -121.423% |
| Clene Inc. | -49.5 Million USD | -206.206% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -882.814% |
| BeyondSpring Inc. | -21.02 Million USD | -620.936% |
| Synlogic, Inc. | -57.28 Million USD | -164.628% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -1173.708% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -1300.185% |
| Peak Bio, Inc. | -1259.26 USD | -12037445.86% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -305.652% |
| Krystal Biotech, Inc. | 10.93 Million USD | 1486.608% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -5.929% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | 53.374% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -3181.774% |
| MannKind Corporation | -11.93 Million USD | -1169.76% |
| Ikena Oncology, Inc. | -68.16 Million USD | -122.375% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -621.313% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -63.111% |
| Gossamer Bio, Inc. | -179.81 Million USD | 15.701% |
| CohBar, Inc. | -11.96 Million USD | -1167.2% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -487.808% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -402.766% |
| Legend Biotech Corporation | -518.25 Million USD | 70.751% |
| Mural Oncology plc | -207.44 Million USD | 26.929% |
| Disc Medicine, Inc. | -76.42 Million USD | -98.333% |
| Champions Oncology, Inc. | -7.27 Million USD | -1983.342% |
| REGENXBIO Inc. | -263.49 Million USD | 42.472% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -1328.276% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -219.091% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -299.079% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -51.337% |
| Vaxart, Inc. | -82.46 Million USD | -83.816% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 45516.658% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -303.766% |
| Cellectis S.A. | -101.05 Million USD | -49.996% |
| Longeveron Inc. | -21.41 Million USD | -607.906% |
| Repare Therapeutics Inc. | -93.79 Million USD | -61.61% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 71.718% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -112.992% |
| Revolution Medicines, Inc. | -436.36 Million USD | 65.262% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -2206.863% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -391.773% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -118.632% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -134.172% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -1445.041% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 104.188% |
| Denali Therapeutics Inc. | -145.22 Million USD | -4.379% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -125953.187% |
| Veru Inc. | -93.15 Million USD | -62.726% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -460.82% |
| Cingulate Inc. | -23.53 Million USD | -544.08% |
| Passage Bio, Inc. | -102.06 Million USD | -48.521% |
| Context Therapeutics Inc. | -23.96 Million USD | -532.543% |
| Exicure, Inc. | -16.91 Million USD | -796.204% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | 19.762% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -301.398% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -2229.437% |
| Nuvalent, Inc. | -126.21 Million USD | -20.096% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -1341.508% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -74.477% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -396.281% |
| OmniAb, Inc. | -50.61 Million USD | -199.461% |
| Anew Medical, Inc. | 1.34 Million USD | 11360.767% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -844.743% |
| Lipocine Inc. | -16.35 Million USD | -827.001% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -128.31% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -138.059% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -259.257% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -216.017% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -664.379% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 72.006% |
| Ocugen, Inc. | -63.07 Million USD | -140.312% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -58.342% |
| Q32 Bio Inc. | -112.96 Million USD | -34.191% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -781.712% |
| Alumis Inc. Common Stock | -154.99 Million USD | 2.199% |
| Equillium, Inc. | -13.33 Million USD | -1036.738% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -151.108% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -1797.685% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -704.107% |
| Dominari Holdings Inc. | -22.88 Million USD | -562.46% |
| Edesa Biotech, Inc. | -8.37 Million USD | -1710.085% |
| vTv Therapeutics Inc. | -20.25 Million USD | -648.563% |
| Bio-Techne Corporation | 168.1 Million USD | 190.172% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | 56.947% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 217.641% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -24.421% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -299.547% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -34.571% |
| Nkarta, Inc. | -117.5 Million USD | -29.007% |
| BioCardia, Inc. | -11.57 Million USD | -1210.034% |
| Iterum Therapeutics plc | -38.37 Million USD | -295.048% |